The goal of this study was therefore to address the relationship between CCL3, 5 and 18 and the presence and extent of CAD as defined by coronary computed tomography angiography (CCTA) in a cohort of patients with stable chest pain. This evidence concerns the gene CCL3 and coronary artery disorder.